Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1137-1150.e6
Open Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
José Mateus, Jennifer M. Dan, Zeli Zhang, et al.
Science (2021) Vol. 374, Iss. 6566
Open Access | Times Cited: 290
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 214
Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages
Jingwen Ai, Xun Wang, Xinyi He, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 8, pp. 1077-1083.e4
Open Access | Times Cited: 167
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 126
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
Wenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110210-110210
Open Access | Times Cited: 122
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection
Guillaume Beaudoin-Bussières, Yaozong Chen, Irfan Ullah, et al.
Cell Reports (2022) Vol. 38, Iss. 7, pp. 110368-110368
Open Access | Times Cited: 114
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner
Roanne Keeton, Simone I. Richardson, Thandeka Moyo-Gwete, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 11, pp. 1611-1619.e5
Open Access | Times Cited: 113
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients
Yuanling Yu, Meiyu Wang, Xiao‐Ai Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 101
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity
Simone I. Richardson, Nelia P. Manamela, Boitumelo M. Motsoeneng, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 2, pp. 100510-100510
Open Access | Times Cited: 74
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
Zezhong Liu, Jie Zhou, Wei Xu, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 269-287
Open Access | Times Cited: 71
Covid-19 vaccine immunogenicity in people living with HIV-1
Lauriane Nault, Lorie Marchitto, Guillaume Goyette, et al.
Vaccine (2022) Vol. 40, Iss. 26, pp. 3633-3637
Open Access | Times Cited: 68
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
Alexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
Cell Host & Microbe (2021) Vol. 30, Iss. 1, pp. 97-109.e5
Open Access | Times Cited: 97
Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity
Shang Yu Gong, Debashree Chatterjee, Jonathan Richard, et al.
Virology (2021) Vol. 563, pp. 134-145
Open Access | Times Cited: 85
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status
Jason Neidleman, Xiaoyu Luo, Matthew McGregor, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 80
T cell immunity to SARS-CoV-2
Julia Niessl, Takuya Sekine, Marcus Buggert
Seminars in Immunology (2021) Vol. 55, pp. 101505-101505
Open Access | Times Cited: 71
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
Thomas Hueso, Anne-Sophie Godron, Émilie Lanoy, et al.
Leukemia (2022) Vol. 36, Iss. 4, pp. 1025-1034
Open Access | Times Cited: 61
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
Ceri A. Fielding, Pragati Sabberwal, James C. Williamson, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 61
Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
Jérémie Prévost, Jonathan Richard, Romain Gasser, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 4, pp. 101151-101151
Open Access | Times Cited: 56
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses
Wanting He, Rami Musharrafieh, Ge Song, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 960-970
Open Access | Times Cited: 56
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients
Ioannis P. Trougakos, Evangelos Terpos, Christina Zirou, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 55
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
Debashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, et al.
Cell Reports (2022) Vol. 38, Iss. 9, pp. 110429-110429
Open Access | Times Cited: 55
Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory
Kathleen M. Wragg, Wen Shi Lee, Marios Koutsakos, et al.
Nature Immunology (2022) Vol. 23, Iss. 5, pp. 768-780
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top